Member Info for Timster

Well as you say it would appear if you want a saliva test then the best option for specificity and sensitivity is the humble Affimer

"Been a few rumours Sona could be talking to Avacta to licence affimers"

Have these rumours come from anywhere credible?
Licensing Affimers for other tests could generate massive loyalties for Avacta. There are an awful lot of tests required to satisfy world demand

Fair play you are still trying. Good luck, now **** off

Great move, nothing at all going for Avacta, what a load of tosh...

8 billion will be next year :)
@jmfw you don't just transfer to the ftse
https://moneycheck.com/ftse-100/

Sure it would be dual and therefore make no difference to our UK holdings. RMP are dual listed too UK and Aus but don't want to talk about that :(

I know the idiots would have you believe avacta have shut down until January but it's possible there might be a bit of news between now and then:

BAMS
- clinically validated and in use in hospitals

LFT
-more manufacturing partners (UK and abroad)
-tech transfer complete
-validation and CE marking for professional use
-Additional commercial opportunities for SARS Licensing and commercial partnerships

AVA6000
-Aiming for UK regulatory filing (CTA)

They are the dogs ******

Course you did shareseeker zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz

Just imagine if the only way to get a sensitive/specific enough mass testing test is an Affimer based test?

gonna need a bigger brewing facility!! (lucky some of the placing money was for this)

bit of a poor deramp for you @merchant I'd expect better, very disappointing, let yourself down..

we don't have a validated test so no

agreed, shakes up the predictable trading pattern

We knew this anyway from what we have been told in numerous presentations including the interim's.

The same affimers are used for ELISA, BAMS and LFT (and SKIN **** test), we know they are highly specific and we also know they detected the mutated COVID virus.

Now we have 2 comercial products, for research purposes initially but things are moving Rapidly (in Pharma terms) towards clinically validated BAMS and then LFT. We know samples were an issue and from what we now know from the media is that test samples should no longer be an issue.

Roll on Q4 (tomorrow) ......

Great find Hurst!

Thanks for your concerns, they are noted.

Have you had a good look at the avacta website and worked out what it is avacta are doing currently?

Bit dramatic global you twat

Avacta is working on what the world needs an ANTIGEN test with results in minutes.

Just for info though avacta has also seen a 650% rise this year

Yorkshire post?
https://www.yorkshirepost.co.uk/business/consumer/avacta-set-momentous-milestones-it-prepares-launch-covid-19-test-2985152

The firm is working with two UK manufacturers to make the test, BBI Solutions and Abingdon Health, and is in talks with a third UK manufacturer, Omega Diagnostics.

have people not read through this??

https://avacta.com/wp-content/uploads/2020/09/Avacta-Group-plc-Interim-Results-September-2020-v2.pdf

seems fairly good to me, not at all PANIC PANIC EVERYTHING'S GONE TO ****E ITS TERRIBLE BLAH BLAH

more like, chill out, and if a third of the things that the presentation covers come off we will do very very well........